Fujian University of Traditional Chinese Medicine, 1 Qiu Yang Road, Fuzhou, Fujian, China.
College of Nursing and Midwifery Brisbane Center, Charles Darwin University, Brisbane, QLD, 4000, Australia.
Support Care Cancer. 2021 Jun;29(6):2885-2893. doi: 10.1007/s00520-021-06094-z. Epub 2021 Feb 27.
To evaluate the quality of published clinical practice guidelines (CPGs) regarding the nutritional risk screening and assessment of cancer patients and to identify high-quality CPGs for clinical healthcare professionals.
Guidelines for the nutritional risk screening and assessment of cancer patients were comprehensively searched in eight electronic databases, including The Lancet, PubMed, Cochrane Library, Excerpta Medica dataBASE (EMBASE), Web of Science, China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBMdisc), and Wan Fang Data, through August 2020. Six relevant guideline databases, including the National Comprehensive Cancer Network (NCCN), the National Guideline Clearinghouse (NGC), the Guideline International Network (GIN), the New Zealand Guidelines Group (NZGG), the China Guideline Clearinghouse (CGC), and Medlive, and relevant nutrition society websites, were also searched through August 2020. The methodological quality of the included CPGs was appraised independently by three assessors using the Appraisal of Guidelines for Research and Evaluation, 2nd edition (AGREE II) tool.
Seven CPGs were located, and the domain with the highest percentage was "clarity of presentation" (85.44%), while the domain with the lowest percentage was "applicability" (40.26%). From the AGREE II results, two guidelines were rated as "strongly recommended," three were assessed as "recommended with modifications," and two were deemed as "not recommended."
Considering that the two "strongly recommended" guidelines were developed within the American and European contexts, translation, validation, and cultural adaptation are recommended prior to implementing these guidelines in other countries or healthcare contexts to improve their effectiveness and sensitivity for local cancer patients.
PROSPERO registration of the study protocol: CRD42020177390 (July 5, 2020).
评估已发表的癌症患者营养风险筛查和评估临床实践指南（CPG）的质量，并为临床医护人员确定高质量的 CPG。
全面检索了 8 个电子数据库中的癌症患者营养风险筛查和评估指南，包括《柳叶刀》、PubMed、Cochrane 图书馆、Excerpta Medica dataBASE（EMBASE）、Web of Science、中国国家知识基础设施（CNKI）、中国生物医学文献数据库（CBMdisc）和万方数据，检索时间截至 2020 年 8 月。同时，还通过 8 月 2020 年的 6 个相关指南数据库，包括美国国家综合癌症网络（NCCN）、国家指南库（NGC）、指南国际网络（GIN）、新西兰指南组（NZGG）、中国指南库（CGC）和 Medlive，以及相关营养学会网站，对相关指南进行了检索。由 3 名评估者独立使用评估研究和评估指南的工具（AGREE II）评估纳入 CPG 的方法学质量。
共检索到 7 项 CPG，各领域中得分最高的是“表述清晰性”（85.44%），得分最低的是“适用性”（40.26%）。根据 AGREE II 结果，有 2 项指南被评为“强烈推荐”，3 项被评为“推荐，修改后推荐”，2 项被评为“不推荐”。
考虑到这 2 项“强烈推荐”的指南是在美国和欧洲的背景下制定的，因此建议在其他国家或医疗保健环境中实施这些指南之前，先进行翻译、验证和文化适应性调整，以提高其对当地癌症患者的有效性和敏感性。
研究方案的 PROSPERO 注册：CRD42020177390（2020 年 7 月 5 日）。
